INSYS Therapeutics to Present at 2018 Cantor Global Healthcare Conference
September 27 2018 - 6:53PM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the
development, manufacture and commercialization of pharmaceutical
cannabinoids and spray technology, announced today that Saeed
Motahari, president and chief executive officer, and Andy Long,
chief financial officer, will present at the upcoming 2018 Cantor
Global Healthcare Conference as follows:
Date: |
|
Tuesday, Oct. 2,
2018 |
Time: |
|
1:05 p.m. Eastern
Time |
Location: |
|
New York, N.Y. |
The presentation will be webcast live at the
aforementioned time, and archived for 90 days thereafter, via the
Investors section of company’s website at https://www.insysrx.com/,
under Presentations & Events. Accessible at the same webpage,
the presentation slides will be available during and after the
conference.
About INSYS
INSYS Therapeutics is a specialty pharmaceutical
company that develops and commercializes innovative drugs and novel
drug delivery systems of therapeutic molecules that improve
patients’ quality of life. Using proprietary spray technology and
capabilities to develop pharmaceutical cannabinoids, INSYS is
developing a pipeline of products intended to address unmet medical
needs and the clinical shortcomings of existing commercial
products. INSYS is committed to developing medications for
potentially treating anaphylaxis, epilepsy, Prader-Willi syndrome,
opioid addiction and overdose, and other disease areas with a
significant unmet
need.C
CONTACT: |
Corporate
Communications |
Investor
Relations |
|
Joe McGrath |
Jackie Marcus or Chris
Hodges |
|
INSYS Therapeutics |
Alpha IR Group |
|
480-500-3101 |
312-445-2870 |
|
jmcgrath@insysrx.com |
INSY@alpha-ir.com |
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Aug 2024 to Sep 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Sep 2023 to Sep 2024